RANI News and Press, Rani Therapeutics Holdings Inc.

SAN JOSE, Calif., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced the promotion of Alireza J...

- A phase 1 study to evaluate safety, tolerability, bioavailability, pharmacokinetics, and weight loss of GLP-1/GLP-2 dual agonist, PG-102, administered orally via RaniPill ® capsule versus subcutaneous injection -  SAN JOSE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Rani Therapeuti...

SAN JOSE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that the company’s ...

2025-11-06 18:02:40 ET Rani Therapeutics press release ( RANI ): Q3 GAAP EPS of -$0.12 in-line. Cash, cash equivalents and marketable securities as of September 30, 2025 totaled $4.1 million, compared to $27.6 million for the year ended December 31, 2024. Rani expects its ...

– Announced up to $1.085 billion collaboration with Chugai Pharmaceutical Co. for multiple high-value therapeutics – – Completed $60.3 million oversubscribed private placement led by Samsara BioCapital with participation from RA Capital Management, Anomaly, Special Si...

2025-11-05 15:22:53 ET ... Read the full article on Seeking Alpha For further details see: Rani Therapeutics: Oral Biologics Vision Still Has Early-Stage Risks

A look at the top 10 most actives in the United States EPWK Holdings Ltd. (EPWK) rose 29.2% to $0.0855 on volume of 1,411,810,058 shares Yueda Digital Holding (YDKG) rose 21.6% to $0.0563 on volume of 591,315,290 shares UTime Limited (WTO) rose 6.9% to $0.0463 on volume of 326,794,845 share...

A look at the top 10 most actives in the United States EPWK Holdings Ltd. (EPWK) rose 29.2% to $0.0855 on volume of 1,384,347,396 shares Yueda Digital Holding (YDKG) rose 21.6% to $0.0563 on volume of 580,113,283 shares AMTD Digital Inc. American Depositary Shares (every five of which repre...

SAN JOSE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that it will present precl...

SAN JOSE, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced the appointment of Abraham...